ARIAD Pharmaceuticals (ARIA)

Add to Watchlists
Create an Alert
23.70 +0.01  +0.02% NASDAQ Jan 19, 16:59 Delayed 2m USD

ARIAD Pharmaceuticals Enterprise Value:

4.840B for Jan. 18, 2017
View 4,000+ financial data types
Browse...
View Full Chart

ARIAD Pharmaceuticals Enterprise Value Chart

Export Data
Save Image
Print Image

ARIAD Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Jan. 18, 2017 4.840B
Jan. 17, 2017 4.829B
Jan. 13, 2017 4.839B
Jan. 12, 2017 4.843B
Jan. 11, 2017 4.841B
Jan. 10, 2017 4.837B
Jan. 9, 2017 4.851B
Jan. 6, 2017 2.907B
Jan. 5, 2017 2.841B
Jan. 4, 2017 2.775B
Jan. 3, 2017 2.641B
Dec. 30, 2016 2.654B
Dec. 29, 2016 2.646B
Dec. 28, 2016 2.679B
Dec. 27, 2016 2.695B
Dec. 23, 2016 2.611B
Dec. 22, 2016 2.543B
Dec. 21, 2016 2.547B
Dec. 20, 2016 2.608B
Dec. 19, 2016 2.596B
Dec. 16, 2016 2.656B
Dec. 15, 2016 2.666B
Dec. 14, 2016 2.672B
Dec. 13, 2016 2.651B
Dec. 12, 2016 2.644B
   
Dec. 9, 2016 2.701B
Dec. 8, 2016 2.759B
Dec. 7, 2016 2.716B
Dec. 6, 2016 2.897B
Dec. 5, 2016 2.817B
Dec. 2, 2016 2.794B
Dec. 1, 2016 2.776B
Nov. 30, 2016 2.856B
Nov. 29, 2016 2.918B
Nov. 28, 2016 2.898B
Nov. 25, 2016 2.986B
Nov. 23, 2016 2.916B
Nov. 22, 2016 2.831B
Nov. 21, 2016 2.881B
Nov. 18, 2016 2.969B
Nov. 17, 2016 2.936B
Nov. 16, 2016 2.738B
Nov. 15, 2016 2.802B
Nov. 14, 2016 2.814B
Nov. 11, 2016 2.652B
Nov. 10, 2016 2.524B
Nov. 9, 2016 2.458B
Nov. 8, 2016 2.038B
Nov. 7, 2016 2.105B
Nov. 4, 2016 1.962B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

ARIA Enterprise Value Benchmarks

Companies
Gilead Sciences 110.33B
Halozyme Therapeutics 1.450B
Seattle Genetics 7.765B

ARIA Enterprise Value Range, Past 5 Years

Minimum 123.63M Oct 31 2013
Maximum 4.851B Jan 09 2017
Average 1.965B

ARIA Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("ARIA", "enterprise_value")
  • Last 5 data points: =YCS("ARIA", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.